# FDA 483 - 3M Company - January 25, 2019

Source: https://www.keypedia.com/records/483/3m-company/ef33068d-0e0a-40f9-89f0-f38291ee9baf

> FDA 483 for 3M Company on January 25, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: 3M Company
- Inspection Date: 2019-01-25
- Product Type: drugs
- Office Name: Minneapolis District Office
- Summary: The FDA inspected 3M Company in Saint Paul, MN, a human drug manufacturer, from January 22-25, 2019. The inspection revealed two significant observations related to quality control failures, including the release of drug product lots that did not meet quality criteria and deficiencies in the quality control unit's procedures for training and mock recalls. These issues indicate a lack of adherence to good manufacturing practices.

## Related Officers

- [Victoria A. Wagoner](https://www.keypedia.com/people/victoria-a-wagoner/3b26259b-4a87-485e-8fd5-b08aa87f6577)
- [Pharmacist at U.S. Public Health Service Commissioned Corps](https://www.keypedia.com/people/anthony-j-ladner/dbb6b53a-80d1-4b47-ae42-6eb2053dfa4b)

Company: https://www.keypedia.com/companies/3m-company/c53d1972-9095-4a54-91f0-6a2d29b0776e

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d